Scarica l'app Stockscreener
0.4484
1.04%
0.0046
Dopo l'orario di chiusura:
.45
0.0016
+0.36%
Precedente Chiudi:
$0.4438
Aprire:
$0.43
Volume 24 ore:
738.82K
Relative Volume:
0.07
Capitalizzazione di mercato:
$26.29M
Reddito:
$106.79M
Utile/perdita netta:
$-8.73M
Rapporto P/E:
-2.242
EPS:
-0.2
Flusso di cassa netto:
$10.81M
1 W Prestazione:
-15.35%
1M Prestazione:
-3.98%
6M Prestazione:
-78.75%
1 anno Prestazione:
-83.87%
Intervallo 1D:
$0.43
$0.4606
Intervallo di 1 settimana:
$0.4207
$0.5509
Portata 52W:
$0.2813
$3.60
Harvard Bioscience Inc Stock (HBIO) Company Profile
Nome
Harvard Bioscience Inc
Settore
Industria
Telefono
(508) 893-8999
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Confronta HBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.4484 | 26.29M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Iniziato | Northland Capital | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Downgrade | Janney | Buy → Neutral |
| 2018-01-24 | Reiterato | Janney | Buy |
| 2018-01-23 | Reiterato | The Benchmark Company | Buy |
| 2016-11-17 | Iniziato | Singular Research | Buy |
| 2015-07-28 | Iniziato | The Benchmark Company | Buy |
Mostra tutto
Harvard Bioscience Inc Borsa (HBIO) Ultime notizie
Financial Fitness Check: Examining Harvard Bioscience Inc (HBIO)’s Key Ratios - DWinneX
Major Improvements In Harvard Bioscience Inc (HBIO) Stock Need To Be Considered - Stocksregister
Harvard Bioscience appoints new board member as director steps down - Worcester Business Journal
What Did We Find About Insider Trading At Harvard Bioscience Inc (NASDAQ: HBIO)? - Stocksregister
Harvard Bioscience appoints new board member By Investing.com - Investing.com India
Harvard Bioscience Approves Incentive Plan Amendment - TipRanks
Harvard Bioscience appoints new board member - Investing.com
Harvard Bioscience Appoints John Duke to Board of Directors | HB - GuruFocus
Harvard Bioscience Appoints John Duke to Board of Directors - The Manila Times
Harvard Bioscience Strengthens Board with Ex-Corning Life Sciences Leader John Duke, Names New Lead Director - Stock Titan
Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st
Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance
Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN
Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Chall - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations - GuruFocus
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast By Investing.com - Investing.com South Africa
Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire
Harvard Bioscience: Q1 Earnings Snapshot - MySA
Harvard Bioscience (HBIO) Reports Q1 2025 Highlights Amid Financ - GuruFocus
Harvard Bioscience Q1 2025 Earnings Call Transcript - MarketBeat
Transcript : Harvard Bioscience, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com
Harvard Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
HBIO Reports Decline in Q1 Revenue Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience earnings matched, revenue topped estimates - Investing.com
Harvard Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Harvard Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) - Seeking Alpha
Harvard Bioscience Q1 2025 slides: Revenue decline and goodwill impairment weigh on results - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast - Investing.com
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceed - GuruFocus
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceeding Estimates; Faces Net Loss Due to Goodwill Impairment - GuruFocus
Harvard Bioscience Q1 Net Income USD -50.34 Million - marketscreener.com
Harvard Bioscience Announces First Quarter 2025 Financial Results | HBIO Stock News - GuruFocus
Harvard Bioscience : Q1 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Report Preview: W - GuruFocus
Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):